Roche Holding AG Participation (RHHVF)
Roche Holding AG Participation (RHHVF) is a profit-participation certificate, or Genussschein, associated with Roche Holding AG and listed on OTC Markets. The instrument reflects the Swiss healthcare group’s underlying business, while the listed security itself should be viewed in the context of its participation structure rather than as ordinary common equity. Roche is active in pharmaceuticals and diagnostics across Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. Its pharmaceutical business covers therapies for anaemia, blood and solid tumors, dermatology, haematology, infectious diseases, inflammatory and autoimmune conditions, neurological disorders, ophthalmology, respiratory disorders, and transplantation. The diagnostics segment includes in vitro tests for diseases such as cancer, diabetes, Covid-19, hepatitis, and human papillomavirus, as well as diagnostic instruments and digital health solutions. Founded in 1896, Roche is based in Basel, Switzerland.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
OTC-RHHV.F
|
—
|
—
|
—
|
$469.08
|
12.2% Upside
|
Fair
|
Great
|
—
|
—
|
8.12
|
1.9%
|
July 23, 2026
|
—
|
—
|
—
|
326.4 B
|
—
|
—
|
82.1%
|
—
|
60.0%
|
—
|